Venlafaxine Hydrochloride NDC 72888-179

NDC codes

FDA NDC Directory

Product NDC (as listed)72888-179Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72888-0179Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72888-179-30	72888017930	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72888-179-30)Marketed from Mar 20, 2020
72888-179-90	72888017990	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72888-179-90)Marketed from Mar 20, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine Hydrochloride
Generic name (nonproprietary): venlafaxine hydrochloride
Active ingredients: Venlafaxine hydrochloride — 37.5 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Advagen Pharma Ltd.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203332
Marketing start: Mar 20, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 72888-179_59dd35fd-571f-707f-e063-6294a90a846bSPL ID 59dd35fd-571f-707f-e063-6294a90a846bSPL set ID 48a75840-64e4-4d44-9a62-009373003105RxCUI 313581, 313583, 313585, 411805UNII 7D7RX5A8MOUPC 0372888271019, 0372888179308, 0372888181301, 0372888180304
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888017930 followed by a unit qualifier and the quantity

Package 72888-0179-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 25, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine hydrochloride extended-release capsules is indicated in adults for the treatment of: Major Depressive Disorder (MDD) [see Clinical Studies (14.1) ] Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] Panic Disorder (PD) [see Clinical Studies (14.4) ] Venlafaxine hydrochloride extended-release capsules is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: Major Depressive Disorder (MDD) ( 1 ) Generalized Anxiety Disorder (GAD) ( 1 ) Social Anxiety Disorder (SAD) ( 1 ) Panic Disorder (PD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203332

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203332
Product	Strength	Form · route	Labeler	Product NDC
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	Advagen Pharma Ltd.	72888-180
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 150 mg/1	Capsule, Extended releaseOral	Advagen Pharma Ltd.	72888-181
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 100 mg/1	Capsule, Extended releaseOral	Advagen Pharma Ltd.	72888-271